Saturday, 5 January 2019

Week 178 Review - Flat start to 2019

2019 started off very flat. OPTI:Optibiotix tried to make me finish in the red by dropping 1p, but the rest of the portfolio rallied around and made up the deficit, resulting in a gain of £211. That's just over £1,000 given the OPTI:Optibiotix drop would have cost £800. This leaves the buffer between value and cost at £4,283 and overall portfolio value of £101,606.

There was only one poor performer this week, with IQE:IQE dropping another 5% to extend the misery and go 56% down on purchase price. Thank goodness I sold out the majority of my holding for thousands of profit when I did!

A great run of climbers this week, and there had to be to offset the £800 drop in OPTI:Optibiotix. First winner was MTFB:Motif Bio, climbing 7% for the second week in a row. People are smelling FDA decision and getting excited. It's a shit or bust share!

Another 7% riser was TLOU:Tlou Energy. This is still 48% down and the only reason I haven't topped up is fear that they will sell the company before producing any gas or building any power stations - oh - and my decision that I really shouldn't be investing in fossil fuels on conservation grounds. My ethics don't include taking a loss though, so I'm sticking with them for now.

TEK:Tekcapital managed a 9% climb this week, which is a surprise as they are showing no signs of ever making a profit. They are 53% down so still no chance of getting rid unless I take a big hit.

Not surprisingly my two best performers this week were gold miners. PAF:Pan African Resources went up 10% and are now up by 22% altogether, with £310 paper profits. I'm sure it won't be too long before a production update from their new project, and then these should double.

Share of the Week goes to CEY:Centamin as it starts what I hope is a significant recovery. My ISA holding climbed 10% on purchase price, but with my SIPP holding being significantly cheaper to buy, that climbed 13%. The ISA is only down £86 now, whereas the SIPP is up by £335 so this is in profit and has dished out £23 dividends. I can see no reason why it won't return in the short term to the price it enjoyed before hitting the poor grade seam. That will see it go from 121p to 163p and the PE ratio should climb to a more sensible figure than the current 8. I'll continue to hold for the dividend and as part of my gold hedge.




Flat for a few weeks now - quite a relief after recent volatility.

Here's the ISA and share accounts



Weekly Change
Cash £46.66
+£0
Portfolio cost £56,971.94
+£0
Portfolio sell value (bid price - commission) £58,630.29 (2.9%) +£141.05
Potential profits £11,366.93
-£505.96
Yr 4 Dividends £60.50
+£0
Yr 4 Profit from sales £814.53
+£0
Yr 4 Average monthly cash profit £168.66 (3.6%) -£8.03
Total Dividends £1,298.83
+£0
Total Profit from sales £19,511.65
+£0
Average monthly cash profit £502.60 (10.6%) -£2.84
(Sold stocks profit + Dividends - Fees / Months)

OPTI:Optibiotix is the only thing in profit, so the £505 drop was down to the 1p fall there. Fortunately the rest of the portfolio fought back, made up the loss and also added £141. Well done chaps!




Way too close to the line for comfort, but on the right side.

Here's the SIPP after week 162



Weekly Change
Cash £138.92
+£0
Portfolio cost £37,825.18
+£0
Portfolio sell value (bid price - commission) £41,407.70 (9.5%) +£52.88
Potential profits £7,673.65
+£73.68
Yr 4 Dividends £0
+£0
Yr 4 Interest £0.01
+£0
Yr 4 Profit from sales £0
+£0
Yr 4 Average monthly cash profit -£10.89 (-0.3%) +£2.17
Total Dividends £1,342.25
+£0
Total Interest £0.04
+£0
Total Profit from sales £10,544.92
+£0
Average monthly cash profit £310.64 (9.8%) -£1.93
(Sold stocks profit + Dividends - Fees / Months)

This portfolio did even better to remove the OPTI:Optibiotix drop, as that would have chopped around £300 off potential profits, but they are up by £73 mainly thanks to the gold miners. A few deepening losses mean the overall value only climbed by £52 which is as flat as this account has been for a long time.




Still a nice gap on this one. I'm anticipating the red line will go up in steps by £1,000 every 2 months as I transfer out of my work pension into here. I've made so much more since doing the transfer than I did with their rubbish funds.

Here's the trading performance



Weekly Change
Cash £18.80
+£0
Portfolio cost £2,321.29
+£0
Portfolio sell value (bid price - commission) £1,364.32 (-41.2%) +£17.74
Potential profits £0
+£0
Year 3 Dividends £17.33
+£0
Year 3 Profit £177.06
+£0
Yr 3 Average monthly cash profit £35.10 (18.1%) -£1.52
Dividends £18.48
+£0
Profit from sales -£64.29
+£0
Average monthly cash profit -£1.55 (-0.8%) +£0.01
(Sold stocks profit + Dividends - Fees / Months)

Any week this goes up is a massive bonus. Unfortunately four out of the five shares in the account are around 50% down, and the fifth is 16% down, but that's CAML:Central Asia Metals and is showing signs of recovery. I'm so desperate to make £65 profit on a sale so I can get in the black, but it's looking a long way off. Why oh why didn't I sell TAP:Taptica and pocket £100 profit when I had the chance? LION:Lionsgold is making noise about re-listing soon, so that may be the best bet if there's a re-listing spike.




I don't know why I have a trendline on here - it's completely flawed given the amount I've injected. I'd be better having a trend line representing the difference between cost and value - now there's a thought!




I hate what I'm seeing, but I really like the chart! So next week I'll introduce this chart for each account and we'll see how the paper profits are looking. Here we see that the account was briefly in profit for about 4 weeks and is now in a pitiful state.

At least 2019 started off positively - if only just. Let's see how long we can keep the positive weeks going - one week and counting!

No comments:

Post a Comment